Sermonix Pharmaceuticals Shares ASCO Poster Presentation on Longer Patient Follow-up Results for…
CHICAGO, June 05, 2023 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat metastatic breast cancers harboring ESR1 mutations, today…